Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
Qian Ding, Jinbiao ZhanDepartment of Biochemistry, Zhejiang University School of Medicine, Hangzhou, People's Republic of ChinaAbstract: Small-cell lung cancer (SCLC) is the most aggressive form of lung cancer characterized by early metastasis and high mortality. In recent years, monotherapy...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-08-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/amrubicin-potential-in-combination-with-cisplatin-or-carboplatin-to-tr-a13874 |